From the genetics to the prevention of stroke;De la genética a la prevention del ictus

Revista de Neurologia

Volumn 29, Issue 9, 1999, Pages 836-847

  Berciano, J ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Embolism; Genetics; Hemorrhage; Risk factors; Stroke; Thrombosis

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEINE; LIPOPROTEIN A; APOLIPOPROTEIN;

BRAIN EMBOLISM; BRAIN HEMORRHAGE; CONFERENCE PAPER; DYSLIPOPROTEINEMIA; FAMILY HISTORY; GENETIC RISK; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK FACTOR; STROKE; TWINS; VASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHROMOSOME 21; GENE EXPRESSION; GENETICS; REVIEW;

APOLIPOPROTEINS; CEREBROVASCULAR ACCIDENT; CHROMOSOMES, HUMAN, PAIR 21; GENE EXPRESSION; HUMANS; RISK FACTORS;

EID: 17144462355     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2909.99169     Document Type: Article

References (68)

1. Meyer JS, Imai A, Shinohara T, Causes of cerebral ischemia and infarction. In Toole JF, ed. Handbook of clinical neurology. Vol. 11. Amsterdam: Elsevier Science Publisher; 1989. p. 155-73.
2. Natowicz M, Kelley RI, Mendelian etiologies of stroke. Ann Neurol 1987; 22: 175-92.
3. Alberts MJ, Genetics aspects of cerebrovascular disease. Stroke 1991; 22: 276-80.
4. DeGraba TJ, Penix L, Genetics of ischémie stroke. Curr Opin Neurol 1995; 8: 24-9.
5. Rastenyté D, Tuomilheto J, Sarti C, Genetics of stroke: a review. J Neurol Sci 1998; 153: 132-45.
6. Älvarez J, Matias-Guiu J, Sumalla J, et al. Ischémie stroke in young adults. I, Analysis of the etiological subgroups. Acta Neurol Scand 1989; 80: 28-34.
7. Leno C, Berciano J, Combarros O, et al. Etiologic study of stroke in 95 young adults. Neurologia 1995; 10: 283-7.
8. Barinagarrementeria F, Gonzâlez-Duartc A, et al. Cerebral infarction in young women: analysis of 130 cases. Eur Neurol 1998; 40: 228-33.
9. Brown RB, Amyotrophic lateral sclerosis. Insights from genetics. Arch Neurol 1997; 54: 1246-50.
10. Mohr JP, Hartmann A, Treatment of acute ischémie stroke: where are we? Neurologia 1999; 14: 6-10.
11. McKusick VA, Mendelian inheritance in man. Baltimore: Johns Hopkins University Press; 1998.
12. Connor M, Ferguson-Smith M, Essential medical genetics. Oxford: Blackwell Science; 1997.
13. Kiely DK, Wolf PA, Cupples A, et al. Familial aggregation of stroke. The Framingham Study. Stroke 1993; 24: 1366-71.
14. Graffagnino C, Gasecki AP, Doig GS, et al. The importance of family history in cerebrovascular disease. Stroke 1994; 25: 1599-604.
15. Jousilahti P, Rastenyté D, Tuomilheto J, et al. Parenteral history of cardiovascular disease and risk of stroke. A prospective follow-up of 14,371 middle-aged men and women in Finland. Stroke 1997; 28: 1361-6.
16. Brass LM, Isaacsohn JL, Merikangas KR, et al. A study of twins and stroke. Stroke 1992; 23: 221-3.
17. Hunt SC, Hasstedt SJ, Kuida H, et al. Genetic hereditability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 1989; 129: 625-38.
18. Konishi M, Iso H, Komachi Y, et al. Association of serum total cholesterol, different types of stroke and stenosis distribution of cerebral arteries. The Akita Pathological Study. Stroke 1993; 24: 954-64.
19. Nagayama M, Shinohasa Y, Nagayama T, Lipoprotein (a) and ischémie cerebrovascular disease in young adults. Stroke 1994; 25: 74-8.
20. Couderc R, Mathiews F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischémie cerebrovascular disease: a case control study. Stroke 1993; 24: 661-4.
21. Pedro-Botet J, Senti M, Nogués X, et al. Lipoprotein and apolipoprotein profile in men with ischémie stroke: role of lipoprotein (a), triglycéride rich lipoproteins, apolipoprotein E polymorphism. Stroke 1992; 23: 1556-62.
22. Aalto-Setala K, Palomaki H, Miettinen H, et al. Genetic risk factors and ischémie cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme. Ann Med 1998; 30: 224-33.
23. Vonsattel JPG, Hedley-Whyte ET, Homocystinuria. In Toole JF, ed. Handbook of clinical neurology. Vol. 11. Amsterdam: Elsevier Science Publisher; 1989. p. 325-34.
24. Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folie acid intakes. JAMA 1995;27:1049-57.
25. Handin RI, Hemorragia y trombosis. En Fauci AS, et al, eds. Harrison. Principles de medicina intema. Madrid: McGraw-Hill Interamericana; 1998. p. 368-92.
26. Barinagarrementeria F, Cantû-Brito C, de la Pena A, et al. Prothrombotic states in young people with idiopathic stroke. A prospective study. Stroke 1994; 25: 287-90.
27. Fisher M, Fernândez JA, Ameriso SF, et al. Activated protein C resistance in ischémie stroke not due to factor V arginine506-glutamine mutation. Stroke 1996; 27:'1163-6.
28. Ganesan V, McShane MA, Liesner R, et al. Inherited prothrombotic states and ischémie stroke in childhood. J Neurol Neurosurg Psychiatry 1998:65:508-11.
29. Brey RL, Coull BM, Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation. Stroke 1996; 27:1719-20.
30. Braunwald E, Cardiopatïas vasculares. En Fauci AS et al, eds. Harrison. Principios de medicina intema. Madrid: McGraw-Hill Interamericana; 1998. p. 1498-512.
31. Colucci WS, Braunwald E, Tumores cardiacos, manifestaciones cardiacas de las enfermedades sistémicas y lesiones traumaticas del corazôn. En Fauci AS et al, eds. Harrison. Principios de medicina intema. Madrid: McGraw-Hill Interamericana; 1998. p. 1531-5.
32. Roach ES, Neurocutaneous syndromes. Pediatr Clin North Am 1992; 39: 591-620.
33. Roman G, Fisher M, Perl DP, et al. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol 1978; 4: 130-44.
34. Guttmacher AE, Marchuk DA, White RI, Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-24.
35. Joutel A, Corpechot C, Duchos A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383: 707-10.
36. Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet 1995; 346: 934-9.
37. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998; 44:731-8.
38. Chabriat H, Levy C, Taillia M, et al. Patterns of MRI lesions in CADASIL, Neurology 1998; 51: 452-7.
39. Rouchou MM, Maurage CA, CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997; 56: 947-64.
40. Rebollo M, Val JF, Garijo F, et al. Livedo reticularis and cerebrovascular lésions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases. Brain 1983; 106: 965-79.
41. Berciano J, Sneddon syndrome: another Mendelian etiology of stroke. Ann Neural 1988; 24: 586-7.
42. Rehany U, Kassif Y, Rumelt S, Sneddon's syndrome: neuro-ophthalmologic manifestations in a possible autosomal recessive pattern. Neurology 1998; 51: 1185-7.
43. Tietjen GE, Levine SR, Sneddon's syndrome. In Adams HP Jr, éd. Neurobase: cerebrovascular disorders. San Diego: Ann Arbor Publishing; 1998.
44. Beutler E, Alteraciones de la hemoglobina. En Fauci AS et al, eds. Harrison. Principios de medicina interna. Madrid: McGraw-Hill Interamericana; 1998. p. 737-45.
45. Ross Russell RW, Wade JPH, Hematological causes of cerebrovascular disease. In Toole JF, éd. Handbook of clinical neurology. Vol. 11. Amsterdam: Elsevier Science Publisher; 1989. p. 463-81.
46. Adams RJ, Nichols FT, Sickle cell anemia, sickle cell trait and thalassemia. InToole JF, ed. Handbook of clinical neurology. Vol 11. Amsterdam: Elsevier Science Publisher; 1989. p. 503-15.
47. Lyon G, Adams RD, Kolodny EH, Neurologic of hereditary metabolic diseases of children. New York: McGraw-Hill; 1996.
48. Me Govern MM, Enfermedades poracümulo lisosomico. En Fauci AS et al, eds. Harrison. Principios de medicina interna. Madrid: McGrawHill Interamericana; 1998. p. 2467-75.
49. Sandok A, Fibromuscular dysplasia of the cephalic arterial system. In Toole JF, ed. Handbook of clinical neurology. Vol 11. Amsterdam: Elsevier Science Publisher; 1989. p. 283-92.
50. Rebollo M, Quintana F, Combarros O, et al. Giant aneurysm of the intracavemous carotid artery and bilateral carotid fibromuscular dysplasia. J Neurol Neurosurg Psychiatry 1983; 46: 284-5.
51. Kitamura K, Fukui M, Oka K, et al. Moyamoya disease. In Toole JF, ed. Handbook of clinical neurology. Vol 11. Amsterdam: Elsevier Science Publisher; 1989. p. 293-306.
52. Leno C, Mate I, Cid C, et al. Autoimmunity in Down's syndrome: another possible mechanism of moyamoya disease. Stroke 1998; 29: 868-9.
53. Houkin K, Abe H, Yoshimoto T, et al. Is 'unilateral' moyamoya disease different from moyamoya disease? J Neurosurg 1996; 85: 772-6.
54. Baraitser M, The genetic of neurological disorders. Oxford: Oxford University Press; 1990.
55. Rebollo M, Berciano J, Combarros O, et al. Nevus sebâceo de Jadashson y nevus unius lateris: a propösito de una observacion con manifestaciones displâsicas multiples. Med Clin (Bare) 1979; 72: 106-10.
56. Leno C, Sedano MJ, et al. Congenital giant pigmented nevus and intracranial arteriovenous malformation. Surg Neurol 1989; 31: 407-8.
57. Siegel AM, Andermann E, Badhwar A, et al. Anticipation in familial cavernous angioma: a study of 52 families from International Familial Cavernous Angioma Group. Lancet 1998; 352: 1676-7.
58. Requena I, Arias M, Lopez-Ibor L, et al. Cavernomas of the central nervous system: clinical and neuroimaging manifestations in 47 patients. J Neurol Neurosurg Psychiatry 1991; 54: 590-4.
59. Zabramski JM, Wascher TM, Spetzler R, et al. The natural history of familial cavernous malformations: results of ongoing study. J Neurosurg 1994; 80: 422-32.
60. Ter Berg HWM, Dippel DWJ, Limburg M, et al. Familial intracranial aneurysms. A review. Stroke 1992; 23: 1024-30.
61. Schievnik V, Intracranial aneurysms. N Engl J Med 1997; 336: 28-40.
62. Fulbright RK, Chaloupka JC, Putman CH, et al. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 1998; 19: 477-84.
63. Mäher ER, Kaelin WO, Von Hippel-Lindau disease. Medicine 1997; 76: 388-91.
64. Huson SM, Hughes RAC, The neurofibromatoses. A pathogenetic and clinical overview. London: Chapman Hall Medical; 1994.
65. Karnes PS, Neurofibromatosis: a common neurocutaneous disorder. Mayo Clin Proc 1998; 73: 1071-6.
66. Roach ES, Congenital cutaneovascular syndromes. In Toole JF, ed. Handbook of clinical neurology. Vol 11. Amsterdam: Elsevier Science Publisher; 1989: 443-62.
67. Prockop DJ, Kuivaniemi H, Tromp G, Enfermedades hereditarias del tejido conectivo. En Fauci AS et al, eds. Harrison. Principios de medicina intema. Madrid: McGraw-Hill Interamericana; 1998. p. 2483-97.
68. Graffagnino C, Herbstreicht MH, Roses AD, et al. A molecular genetic study of intracerebral hemorrhage. Arch Neurol 1994; 51: 981-4.